Eyonis® is a suite of Software as a Medical Device (SaMD) that leverages advanced Data Science (DS) & Artificial Intelligence (AI) technologies to analyze medical imaging, supporting radiologists & other healthcare professionals in identifying cancers at the earliest stage, even when invisible to the human eye. Our flagship product, eyonis® LCS, is an AI/ML tech-based end-to-end Computer-Assisted detection & diagnosis (CADe/CADx) SaMD developed to aid cancer diagnosis and improve clinical management of patients, designed to enable early detection, localization and characterization of lung nodules on chest CT images. eyonis® LCS is FDA-cleared & CE-marked in 2026, available for commercial sales in the US & EU markets.
| Website | https://eyonis.ai/ |
| Employees | 24 (14 on RocketReach) |
| Founded | 2020 |
| Industry | Hospitals and Health Care |
Looking for a particular Eyonis, Inc. employee's phone or email?
Thomas Bonnefont is the Chief Operating Officer and Chief Commercial Officer - eyonis oncology - Median Technologies of Eyonis, Inc..
14 people are employed at Eyonis, Inc..
Eyonis, Inc. is based in San Francisco, California.